Replies to post #162453 on Biotech Values

[DewDiligence]

ABT reports one-year data for ABSORB bioresorbable stent compared to Xience:

http://finance.yahoo.com/news/absorb-ii-study-shows-abbotts-150000928.html

ABSORB is undergoing a phase-3 trial for US approval. The product is already launched in all major countries except the US, Japan, and China.